![]() |
Name |
6'- O-desmethylcandidusin B
|
Molecular Formula | C19H14O7 | |
IUPAC Name* |
3-(3,4-dihydroxyphenyl)-4-methoxydibenzofuran-1,7,8-triol
|
|
SMILES |
COc1c(-c2ccc(O)c(O)c2)cc(O)c2c1oc1cc(O)c(O)cc12
|
|
InChI |
InChI=1S/C19H14O7/c1-25-18-9(8-2-3-11(20)12(21)4-8)5-15(24)17-10-6-13(22)14(23)7-16(10)26-19(17)18/h2-7,20-24H,1H3
|
|
InChIKey |
WWDZIQMPRWVASF-UHFFFAOYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Molecular Weight: | 354.31 | ALogp: | 3.8 |
HBD: | 5 | HBA: | 7 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 123.5 | Aromatic Rings: | 4 |
Heavy Atoms: | 26 | QED Weighted: | 0.337 |
Caco-2 Permeability: | -5.399 | MDCK Permeability: | 0.00000711 |
Pgp-inhibitor: | 0.01 | Pgp-substrate: | 0.014 |
Human Intestinal Absorption (HIA): | 0.042 | 20% Bioavailability (F20%): | 0.66 |
30% Bioavailability (F30%): | 0.992 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 93.16% |
Volume Distribution (VD): | 0.568 | Fu: | 10.12% |
CYP1A2-inhibitor: | 0.954 | CYP1A2-substrate: | 0.638 |
CYP2C19-inhibitor: | 0.059 | CYP2C19-substrate: | 0.048 |
CYP2C9-inhibitor: | 0.602 | CYP2C9-substrate: | 0.725 |
CYP2D6-inhibitor: | 0.069 | CYP2D6-substrate: | 0.569 |
CYP3A4-inhibitor: | 0.107 | CYP3A4-substrate: | 0.103 |
Clearance (CL): | 15.97 | Half-life (T1/2): | 0.895 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.091 |
Drug-inuced Liver Injury (DILI): | 0.979 | AMES Toxicity: | 0.722 |
Rat Oral Acute Toxicity: | 0.141 | Maximum Recommended Daily Dose: | 0.878 |
Skin Sensitization: | 0.95 | Carcinogencity: | 0.13 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.932 |
Respiratory Toxicity: | 0.145 |